Ashland Global Holdings Inc has received updated analyst insights and price targets from major financial institutions such as UBS and Morgan Stanley. The report outlines recent stock upgrades and down
Yahoo Finance UK · 2026-10-09 15:40
Ashland Global Holdings Inc shares rose 3% following reports that private equity firms and Clariant submitted initial bids for a potential sale amid activist investor pressure.
TradingView · 2026-10-07 12:11
Ashland Global Holdings reported Q2 2026 EPS of $0.91, missing estimates, with revenue below consensus. It anticipates 18.16% earnings growth next year, scheduling Q4 results for November 3, 2026.
MarketBeat · 2026-10-02 14:26
Ashland Inc. director Sanat Chattopadhyay acquired 212 Common Stock Units on September 30, 2026, under the Deferred Compensation Plan, bringing his total balance to 2,407 units.
Stock Titan · 2026-10-01 20:26
Ashland director Steven D. Bishop purchased 368 common stock units at $67.92 each under the Deferred Compensation Plan, increasing his total holdings to 6,123 units.
Stock Titan · 2026-10-01 20:26
Ashland Global Holdings Inc. released a detailed profile for its 6.875% bond maturing in 2043. The document outlines issuer business segments, bond terms, and credit risk assessment.
TradingView · 2026-09-30 04:25
Ashland Global Holdings shares rose 30% in six months, outperforming the industry due to cost reductions and portfolio optimization. The firm prioritizes high-value specialty ingredients and innovatio
TradingView · 2026-09-29 10:56
Ashland Inc. launched agrimer eco-disperse OD TVO, a crop-protection dispersant derived from transformed vegetable oil. The sustainable product offers biodegradable, microplastic-free solutions for no
MyChesCo · 2026-09-28 10:27
Ashland Inc. extended its European receivables securitization program to September 2029 with a €125 million limit, appointing Bank of America Europe DAC as the new Committed Purchaser.
Kalkine Media · 2026-09-26 04:54
Ashland Global Holdings Inc presented its innovation strategy and technology platforms during its Innovation Day 2026 webcast. The event highlighted science-driven solutions driving scalable growth an
Cosmetics Business · 2026-09-25 15:28
Ashland Global Holdings Inc submitted a Form 4 filing on September 23, 2026, disclosing changes in beneficial ownership by insiders as reported by Investing.com.
Investing.com Nigeria · 2026-09-23 22:06
Ashland's SVP and CTO Musa Osama M converted 10,418 restricted stock units into common shares at $69.06 per share, with 3,647 shares withheld for taxes, raising direct holdings to 37,577.
Stock Titan · 2026-09-23 21:49
Ashland Inc. globally launched Agrimer Eco-Disperse OD TVO, a vegetable oil-derived polymeric dispersant for crop protection formulations designed to prevent settling and nozzle clogging while remaini
Investing.com · 2026-09-22 11:58
Ashland Global Holdings has launched agrimer eco-disperse OD, a biodegradable, microplastic-free polymeric dispersant derived from transformed vegetable oils designed for non-aqueous crop protection f
Stock Titan · 2026-09-22 10:58
Ashland Inc. launched agrimer™ eco-disperse OD, a new polymeric dispersant based on its Transformed Vegetable Oils technology. This nature-based product targets sustainable non-aqueous crop protection
GlobeNewswire · 2026-09-22 04:58
Ashland Inc. will host an Innovation Day webcast on September 17, 2026, featuring leadership updates on technology platforms and commercial progress. Attendees can engage in a moderated Q&A session wi
GlobeNewswire · 2026-09-16 18:25
Ashland Global Holdings Inc will host a virtual Innovation Day on September 17, 2026, presenting technology platforms and commercial progress aimed at driving organic growth.
The Manila Times · 2026-09-01 22:47
Ashland has commercially launched permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drug products. The excipient supports oral alternatives to injectable therapie
Investing.com · 2026-08-24 11:42
Ashland Inc. launched Permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drugs such as GLP-1 agonists. This excipient aims to improve formulation consistency and s
GlobeNewswire · 2026-08-24 10:42
Ashland has launched permexa™ sodium caprate, an intestinal permeation enhancer designed to facilitate the oral delivery of peptides and biologics such as GLP-1 agonists. This excipient aims to improv
Stock Titan · 2026-08-24 10:42
Ashland Inc. received a Moderate Buy consensus from twelve brokerages with a $73.90 average price target, supported by high institutional ownership and a quarterly dividend.
MarketBeat · 2026-08-14 06:41
Massachusetts Financial Services filed an amended Schedule 13G disclosing a 4.5% beneficial ownership stake in Ashland Inc., holding over 2 million shares as of June 30, 2026.
Stock Titan · 2026-08-12 20:40
Omega Advisors increased its stake in specialty materials firm Ashland Inc by 1.215 million shares, though analyst models suggest the stock remains 9% overvalued despite strong financial health scores
GuruFocus · 2026-08-12 01:11
Ashland Inc. has announced updates to its Board of Directors' committee assignments for new directors Allen A. Spizzo and Peter T. Thomas, effective August 7, 2026.
Kalkine Media · 2026-08-11 05:43
An analyst suggests Ashland Global Holdings Inc., a chemicals maker, could be valued at $90 per share in a potential takeover. The company is considering a sale following received takeover interest.
Seeking Alpha · 2026-08-10 14:11
Ashland Global Holdings Inc. announced a quarterly dividend and established a Capital Allocation Advisory Committee following an agreement with Ancora Holdings Group. These changes aim to influence in
Simply Wall Street · 2026-08-09 16:11
Ashland Global Holdings Inc declared a quarterly cash dividend of $0.42 per share, payable on September 15, 2026, to shareholders of record as of September 1, 2026.
Stock Titan · 2026-08-08 09:11
Ashland Global Holdings Inc declared a quarterly cash dividend of $0.42 per share, payable on September 15, 2026. Stockholders of record as of September 1, 2026, will receive the payment.
Caledonian Record · 2026-08-07 23:39
Ashland Inc. shares rose 6% after reports emerged that the chemical maker is exploring a potential sale. The company has engaged Citigroup and Lazard to solicit offers from strategic and private equit
Seeking Alpha · 2026-08-07 16:14
Analysts raised Ashland Inc.'s average 12-month price target to $79.91, implying 11% upside, with a consensus Buy rating from 12 analysts.
TradingView · 2026-08-06 23:39